Fund Holdings

Krensavage Asset Management, LLC

Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
SANOFI-ADR(SNY)0323,946+323,946015,6086.10%+15,608
INDIVIOR PHARMACEUTICALS INC(INDV)0339,532+339,532010,3494.05%+10,349
EMBECTA CORP0735,340+735,34006,5002.54%+6,500
UNITED THERAPEUTICS CORP(UTHR)91,28284,282-7,00044,47749,97819.55%+5,501
GSK PLC-SPON ADR(GSK)096,729+96,72905,3382.09%+5,338
BIONTECH SE-ADR(BNTX)059,523+59,52305,2902.07%+5,290
ULTRAGENYX PHARMACEUTICAL IN(RARE)149,634390,879+241,2453,4428,1893.20%+4,747
JAZZ PHARMACEUTICALS PLC(JAZZ)167,816167,816028,52931,72612.41%+3,197
ARDELYX INC0500,000+500,00002,9951.17%+2,995
BIOGEN INC(BIIB)10,00020,000+10,0001,7603,6671.43%+1,907
INMODE LTD(INMD)0120,942+120,94201,6540.65%+1,654
ALKERMES PLC(ALKS)107,822107,82203,0173,8131.49%+796
ABBOTT LABORATORIES05,000+5,00005130.20%+513
REGENERON PHARMACEUTICALS(REGN)4,0004,00003,0873,0911.21%+4
EVOLUS INC100,000157,985+57,9856656490.25%-16
SUPERNUS PHARMACEUTICALS INC(SUPN)313,499280,681-32,81815,58114,5085.67%-1,073
BIOMARIN PHARMACEUTICAL INC(BMRN)524,786524,786031,18829,64511.59%-1,543
VANDA PHARMACEUTICALS INC1,180,3881,180,388010,4118,1563.19%-2,255
EXELIXIS INC(EXEL)493,526415,693-77,83321,63117,8296.97%-3,802
GSK PLC-SPON ADR(GSK)96,7290-96,7294,7440-4,744
ENANTA PHARMACEUTICALS INC2,766,3902,866,138+99,74843,62636,19914.16%-7,427
BIONTECH SE-ADR(BNTX)99,5230-99,5239,4750-9,475
INDIVIOR PLC339,5320-339,53212,1820-12,182
CARDINAL HEALTH INC(CAH)73,7450-73,74515,1550-15,155
SANOFI-ADR(SNY)323,9460-323,94615,6980-15,698
AVADEL PHARMACEUTICALS855,8600-855,86018,4440-18,444
Page 1 of 1